Legal Representation
Attorney
Steven J. Hultquist
USPTO Deadlines
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 20, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Mar 20, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 16, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 21, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 21, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 1, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 16, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 3, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 1, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 1, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; anti-cancer preparations; pharmaceutical compounds for treating cancer; drugs for medical purposes, namely, pharmaceutical drugs for the prevention and treatment of cancer; medicines for human purposes, namely, for the prevention and treatment of cancer; antibodies for medical purposes, namely, for the treatment of cancer; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; pharmaceutical preparations for veterinary use, namely, veterinary pharmaceutical preparations for the treatment of cancer; biological preparations for medical and veterinary purposes, namely, for the prevention and treatment of cancer; antibody drug conjugates for medical purposes, namely, for the prevention and treatment of cancer
Additional Information
Design Mark
The mark consists of the letter "T", followed by a superscripted "2", followed by the letters "P" and "D".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005